Deal date
KANDO id: 14398068
Financial Transaction:
Series C
Ajax Therapeutics Inc
Currency
United States Dollar
Value in original currency
95,000,000
Value in USD
95,000,000
Lead investor
| Investor | Country | Notes | |
|---|---|---|---|
|
Goldman Sachs Alternative Investments |
Initial investment. |
Round participants
| Investor | Country | Notes | |
|---|---|---|---|
|
Boxer Capital LLCBiotech investment firm. |
Initial investment. | |
|
EcoR1 CapitalBiotech-focused investment firm. |
Follow-on investment. | |
|
Eli Lilly & Co |
Initial investment. | |
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Inning One Ventures |
Follow-on investment. | |
|
Point72 Capital Management LLC |
Initial investment. | |
|
RA Capital Management |
Initial investment. | |
|
Schrödinger Inc |
United States | Follow-on investment. |
|
Vivo Capital LLC |
Initial investment. |